{
    "2019-09-11": [
        [
            {
                "time": "2023-10-17",
                "original_text": "安图转债：控股股东减持安图转债204.89万张，占发行总量30% 减持股份",
                "features": {
                    "keywords": [
                        "安图转债",
                        "控股股东",
                        "减持",
                        "204.89万张",
                        "发行总量30%"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "安图生物：控股股东累计减持安图转债68.298万张 减持股份",
                "features": {
                    "keywords": [
                        "安图生物",
                        "控股股东",
                        "累计减持",
                        "68.298万张",
                        "减持股份"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}